Provided by Tiger Fintech (Singapore) Pte. Ltd.

Achieve Life Sciences, Inc.

2.36
-0.0400-1.67%
Post-market: 2.360.00000.00%17:16 EDT
Volume:262.01K
Turnover:634.21K
Market Cap:81.86M
PE:-1.90
High:2.48
Open:2.39
Low:2.36
Close:2.40
Loading ...

Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial

GlobeNewswire
·
10 Feb

Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory

Insider Monkey
·
25 Jan

ACHV: Long-Term Exposure Requirement Complete

Zacks Small Cap Research
·
21 Jan

Achieve Life Sciences appoints Slaoui, Phelan to board of directors

TIPRANKS
·
10 Jan

Achieve Life Sciences Appoints DR. Kristen Slaoui and Nancy Phelan to Its Board of Directors

THOMSON REUTERS
·
10 Jan

Press Release: Achieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to its Board of Directors

Dow Jones
·
10 Jan

Achieve Life Sciences Reaches Milestone in Clinical Trial for Smoking Cessation Drug

MT Newswires Live
·
08 Jan

Achieve Life Sciences (ACHV) Gets a Buy from JonesTrading

TIPRANKS
·
07 Jan

Achieve Life Sciences Inc - FDA Requests Six-Month Safety Exposure Data for Nda Submission

THOMSON REUTERS
·
07 Jan

Achieve Life Sciences Inc - Cytisinicline Nda Submission on Target for Q2 2025

THOMSON REUTERS
·
07 Jan

Achieve Life Sciences Inc - on Track for Nda Submission in Q2 2025

THOMSON REUTERS
·
07 Jan

Achieve Life Sciences Announces Critical Milestone Successfully Reached in Orca-Ol Cytisinicline Clinical Trial Required for Nda Submission

THOMSON REUTERS
·
07 Jan

Achieve Life Sciences Inc - No Safety Concerns Identified in Orca-Ol Trial

THOMSON REUTERS
·
07 Jan

Achieve Life Sciences Inc - Orca-Ol Trial Evaluates Long-Term Safety of 3 Mg Cytisinicline Dosing

THOMSON REUTERS
·
07 Jan

Should You Expect a Strong Re-rating for Achieve Life Sciences (ACHV) Post Results in Q1?

Insider Monkey
·
03 Jan

Achieve Life Sciences, Inc. (NASDAQ:ACHV) down to US$131m market cap, but institutional owners may not be as affected after a year of 0.5% returns

Simply Wall St.
·
21 Dec 2024

Achieve Life Sciences Appoints Mark Oki CFO

MT Newswires Live
·
09 Dec 2024

Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer

THOMSON REUTERS
·
09 Dec 2024

Press Release: Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer

Dow Jones
·
09 Dec 2024

Achieve Life Sciences announces outcome of End-of-Phase 2 meeting with FDA

TIPRANKS
·
03 Dec 2024